Diffuse Large B Cell Lymphoma  >>  Duvyzat (givinostat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Duvyzat (givinostat) / Italfarmaco
2006-002113-12: Open label, uncontrolled, pilot, phase II study of histone-deacetylase inhibitor ITF2357 administered orally to subjects aged over 60 years with primary or secondary DLBCL refractory/ relapsed after conventional chemotherapy with or without prior immunotherapy

 
2
23
Europe
ITF2357,
ITALFARMACO
Primary or secondary DLBCL refractory/relapsed after conventional chemotherapy
 
 

Download Options